Yes , I would say it has value also . The rhamnose binding protein (RBP) on the cell is targeted by Coramsine to kill the cancer cells . To have this mode of action recognised as unique and protected in the worlds most lucrative biotech market is probably worth a great deal if the drug works , and indications are that it does .
Cheers
- Forums
- ASX - By Stock
- SBP
- grant of us patent
SBP
solbec pharmaceuticals limited
grant of us patent, page-2
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SBP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online